HAL (France)
open access
High-Flow Nasal Oxygen Alone or Alternating with Non-Invasive Ventilation in Critically Ill Immunocompromised Patients with Acute Respiratory Failure: A Randomised Controlled Trial
Background: Although non-invasive ventilation (NIV) is recommended for immunocompromised patients with acute respiratory failure in the intensive care unit (ICU), it might have deleterious effects in the most severe patients. High-flow nasal oxygen (HFNO) alone might be an alternative method
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome#835682
- Inflammatory Local Response During OLV: Protective vs Conventional Ventilation Strategy#883283
- Characteristics and Outcomes of Patients With COVID-19 Treated With HFNO and Prone Positioning#1195629
- Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.#1231836
- Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation#1185011
Record · ID 1415278
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive